Literature DB >> 19263098

Docking and molecular dynamics simulation of quinone compounds with trypanocidal activity.

Fábio Alberto de Molfetta1, Renato Ferreira de Freitas, Albérico Borges Ferreira da Silva, Carlos Alberto Montanari.   

Abstract

In this work, two different docking programs were used, AutoDock and FlexX, which use different types of scoring functions and searching methods. The docking poses of all quinone compounds studied stayed in the same region in the trypanothione reductase. This region is a hydrophobic pocket near to Phe396, Pro398 and Leu399 amino acid residues. The compounds studied displays a higher affinity in trypanothione reductase (TR) than glutathione reductase (GR), since only two out of 28 quinone compounds presented more favorable docking energy in the site of human enzyme. The interaction of quinone compounds with the TR enzyme is in agreement with other studies, which showed different binding sites from the ones formed by cysteines 52 and 58. To verify the results obtained by docking, we carried out a molecular dynamics simulation with the compounds that presented the highest and lowest docking energies. The results showed that the root mean square deviation (RMSD) between the initial and final pose were very small. In addition, the hydrogen bond pattern was conserved along the simulation. In the parasite enzyme, the amino acid residues Leu399, Met400 and Lys402 are replaced in the human enzyme by Met406, Tyr407 and Ala409, respectively. In view of the fact that Leu399 is an amino acid of the Z site, this difference could be explored to design selective inhibitors of TR.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19263098     DOI: 10.1007/s00894-009-0468-3

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  27 in total

1.  Python: a programming language for software integration and development.

Authors:  M F Sanner
Journal:  J Mol Graph Model       Date:  1999-02       Impact factor: 2.518

2.  3D QSAR studies on binding affinities of coumarin natural products for glycosomal GAPDH of Trypanosoma cruzi.

Authors:  Irwin R A Menezes; Julio C D Lopes; Carlos A Montanari; Glaucius Oliva; Fernando Pavão; Marcelo S Castilho; Paulo C Vieira; Mônica T Pupo
Journal:  J Comput Aided Mol Des       Date:  2003 May-Jun       Impact factor: 3.686

Review 3.  Chemotherapy of trypanosomiases and leishmaniasis.

Authors:  Simon L Croft; Michael P Barrett; Julio A Urbina
Journal:  Trends Parasitol       Date:  2005-09-08

4.  Mechanism and structure-activity relationships of norspermidine-based peptidic inhibitors of trypanothione reductase.

Authors:  Mark J Dixon; Richard I Maurer; Cristina Biggi; Julen Oyarzabal; Jonathan W Essex; Mark Bradley
Journal:  Bioorg Med Chem       Date:  2005-07-15       Impact factor: 3.641

Review 5.  Automated docking of flexible ligands: applications of AutoDock.

Authors:  D S Goodsell; G M Morris; A J Olson
Journal:  J Mol Recognit       Date:  1996 Jan-Feb       Impact factor: 2.137

6.  A fluoro analogue of the menadione derivative 6-[2'-(3'-methyl)-1',4'-naphthoquinolyl]hexanoic acid is a suicide substrate of glutathione reductase. Crystal structure of the alkylated human enzyme.

Authors:  Holger Bauer; Karin Fritz-Wolf; Andreas Winzer; Sebastian Kühner; Susan Little; Vanessa Yardley; Hervé Vezin; Bruce Palfey; R Heiner Schirmer; Elisabeth Davioud-Charvet
Journal:  J Am Chem Soc       Date:  2006-08-23       Impact factor: 15.419

7.  Computational study of the interaction between TIBO inhibitors and Y181 (C181), K101, and Y188 amino acids.

Authors:  Renato F Freitas; Sérgio E Galembeck
Journal:  J Phys Chem B       Date:  2006-10-26       Impact factor: 2.991

8.  Antitrypanosomal, antileishmanial, and antimalarial activities of quaternary arylalkylammonium 2-amino-4-chlorophenyl phenyl sulfides, a new class of trypanothione reductase inhibitor, and of N-acyl derivatives of 2-amino-4-chlorophenyl phenyl sulfide.

Authors:  Seheli Parveen; Mohammed O F Khan; Susan E Austin; Simon L Croft; Vanessa Yardley; Peter Rock; Kenneth T Douglas
Journal:  J Med Chem       Date:  2005-12-15       Impact factor: 7.446

9.  Use of an additional hydrophobic binding site, the Z site, in the rational drug design of a new class of stronger trypanothione reductase inhibitor, quaternary alkylammonium phenothiazines.

Authors:  M O Khan; S E Austin; C Chan; H Yin; D Marks; S N Vaghjiani; H Kendrick; V Yardley; S L Croft; K T Douglas
Journal:  J Med Chem       Date:  2000-08-10       Impact factor: 7.446

10.  New cytotoxic furoquinones obtained from terpenyl-1,4-naphthoquinones and 1,4-anthracenediones.

Authors:  José M Miguel del Corral; M Angeles Castro; Alaide B Oliveira; Simone A Gualberto; Carmen Cuevas; Arturo San Feliciano
Journal:  Bioorg Med Chem       Date:  2006-07-13       Impact factor: 3.641

View more
  2 in total

1.  Computer-aided drug design platform using PyMOL.

Authors:  Markus A Lill; Matthew L Danielson
Journal:  J Comput Aided Mol Des       Date:  2010-10-30       Impact factor: 3.686

2.  In-silico investigation of antitrypanosomal phytochemicals from Nigerian medicinal plants.

Authors:  William N Setzer; Ifedayo V Ogungbe
Journal:  PLoS Negl Trop Dis       Date:  2012-07-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.